"We've engineered Ruby XL to deliver more volume per coil than any other coil on the market, which may result in cost savings," said Shruthi Narayan, President of Interventional Business at Penumbra, ...
Penumbra, Inc. PEN recently launched the Ruby XL System, the longest, largest and softest coil in the market, followed by its Food and Drug Administration (FDA) clearance. The Ruby XL System is ...
ALAMEDA, Calif., Penumbra, Inc., a global interventional therapies company, today announced the U.S. launch of its new POD ® Packing Coil, designed to be used as a complementary device with Penumbra’s ...
Embolization, Inc. announced findings from the limited-market release of the company’s nitinol enhanced device (NED), which ...
DUBLIN--(BUSINESS WIRE)--The "Global Embolization Coil Market 2019-2023" report has been added to ResearchAndMarkets.com's offering. Analysts have predicted that the embolization coil market will ...
The novel, radiopaque, polymer-based embolic coil from Embolization, Inc., is demonstrating consistent success in its limited-market release, with use cases topping 70 coils. In all cases, across four ...
ALAMEDA, Calif., June 5, 2025 /PRNewswire/ -- Penumbra, Inc (PEN). (NYSE: PEN) announced the U.S. Food and Drug Administration (FDA) clearance and launch of the Ruby ® XL System, the longest, largest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results